You are here:


As a research and teaching university, Charité is a driver of innovation and is guided by a deep sense of responsibility. Many pioneering developments originally started their journey at Charité. Producing innovations that will be used in the prevention and treatment of diseases is the aim of all of our research efforts. It is what more than 3,700 researchers involved in over 1,000 projects, working groups and collaborative partnerships work towards every single day. At the forefront of all these efforts is an interdisciplinary approach to translating basic research findings in experimental molecular biology for application in patient-centered clinical practice.  Many of the different research groups at Charité are committed to interdisciplinary cooperation, producing national as well as international collaborations. Harnessing the potential of this approach will be of particular importance in the future, as most of the significant scientific developments are likely to come from interdisciplinary cooperations. 

Charité is now focusing its efforts on the following six main research areas: neuroscience, oncology, regenerative therapies, cardiology, immunology, and genetics. We are committed to ensuring that these research foci, as well as all other research areas, will continue to produce research of the highest standard. Our work receives a great deal of recognition on both the national and international stage, yet we are also very much committed to serving the people of Berlin. Charité is very much the heart of Berlin-based health care research as well as its driving force. We are now joining forces with the Max Delbrück Center for Molecular Medicine (MDC) to deliver the Berlin Institute of Health (BIH), a joint research enterprise whose systems medicine approach is unique in Germany.

Berliner Institut für Gesundheitsforschung / Berlin Institute of Health (BIH)

The Berlin Institute of Health (BIH) represents the combined strengths of Charité - Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine (MDC). BIH's commitment to the pursuit of translational research is closely intertwined with systems medicine and its characteristically interdisciplinary approach to research.